Search Results

Cyclosporine

• Source: Funk & Wagnalls New World Encyclopedia. 2018, 1p.

Record details

Rapidly Dissolving Trans-scleral Microneedles for Intraocular Delivery of Cyclosporine A.

• Authors : Alrbyawi H; Department of Drug Discovery and Development, Auburn University, Auburn, Alabama, USA.; Pharmaceutics and Pharmaceutical Technology Department, College of Pharmacy, Taibah University, Medina, Saudi Arabia.

Subjects: Cyclosporine* ; Eye*; Animals

• Source: AAPS PharmSciTech [AAPS PharmSciTech] 2024 Feb 01; Vol. 25 (2), pp. 28. Date of Electronic Publication: 2024 Feb 01.Publisher: Springer Country of Publication: United States NLM ID: 100960111 Publication Model: Electronic Cited Medium: Internet ISSN: 1530-9932

Record details

Rituximab in combination with cyclosporine and steroid pulse therapy for childhood-onset multidrug-resistant nephrotic syndrome: a multicenter single-arm clinical trial (JSKDC11 trial).

• Authors : Nozu K; Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-Cho, Chuo-Ku, Kobe, 650-0017, Japan. .; Sako M

Subjects: Cyclosporine*/Cyclosporine*/Cyclosporine*/adverse effects ; Nephrotic Syndrome*/Nephrotic Syndrome*/Nephrotic Syndrome*/diagnosis ; Nephrotic Syndrome*/Nephrotic Syndrome*/Nephrotic Syndrome*/drug therapy

• Source: Clinical and experimental nephrology [Clin Exp Nephrol] 2024 Apr; Vol. 28 (4), pp. 337-348. Date of Electronic Publication: 2023 Nov 27.Publisher: Springer Country of Publication: Japan NLM ID: 9709923 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7799

Record details

Cyclosporine A micellar nasal spray characterization and antiviral action against SARS-CoV-2.

• Authors : Guareschi F; ADDRes Lab, Department of Food and Drug, University of Parma, Parco Area delle Scienze 27/a, 43124 Parma, Italy.; Del Favero E

Subjects: Cyclosporine*/Cyclosporine*/Cyclosporine*/pharmacology ; COVID-19*; Humans

• Source: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2024 Feb 01; Vol. 193, pp. 106673. Date of Publisher: Elsevier Science B.V Country of Publication: Netherlands NLM ID: 9317982 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Consideration of ATG-free therapy with eltrombopag and cyclosporine for severe aplastic anaemia.

• Authors : Groarke EM; Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: .

Subjects: Cyclosporine*/Cyclosporine*/Cyclosporine*/therapeutic use ; Anemia, Aplastic*/Anemia, Aplastic*/Anemia, Aplastic*/drug therapy ; Pyrazoles*

• Source: The Lancet. Haematology [Lancet Haematol] 2024 Mar; Vol. 11 (3), pp. e173-e174. Date of Electronic Publication: 2024 Feb 06.Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Anti-psoriatic characteristics of ROCEN (topical Arthrocen) in comparison with Cyclosporine A in a murine model.

• Authors : Goudarzi R; Division of Research and Development, Pharmin USA, LLC, San Jose, CA, USA.; Min-Ho Kim

Subjects: Cyclosporine*/Cyclosporine*/Cyclosporine*/pharmacology ; Psoriasis*/Psoriasis*/Psoriasis*/drug therapy; Animals

• Source: BMC complementary medicine and therapies [BMC Complement Med Ther] 2024 Feb 24; Vol. 24 (1), pp. 100. Date of Electronic Publication: 2024 Feb 24.Publisher: BioMed Central Country of Publication: England NLM ID: 101761232 Publication Model: Electronic Cited Medium: Internet ISSN: 2662-7671

Record details

The effect of genetic variants in the transcription factor TSPYL family on the CYP3A4 mediated cyclosporine metabolism in kidney transplant patients.

• Authors : Zhai Q; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.; Moes DJAR

Subjects: Cyclosporine*/Cyclosporine*/Cyclosporine*/pharmacokinetics ; Kidney Transplantation*/Kidney Transplantation*/Kidney Transplantation*/adverse effects; Male

• Source: Clinical and translational science [Clin Transl Sci] 2024 Feb; Vol. 17 (2), pp. e13729.Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Multiplex Immunosuppressant (ISD) Method for the Measurement of Cyclosporine A, Tacrolimus, Sirolimus/Rapamycin, and Everolimus in Whole Blood Using MassTrak™ Kit.

• Authors : Zhang A; Department of Pathology and Laboratory Medicine, Tufts Medical Center, Boston, MA, USA.; Conklin SE

Subjects: Immunosuppressive Agents* ; Cyclosporine*/Cyclosporine*/Cyclosporine*/chemistry; Humans

• Source: Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2024; Vol. 2737, pp. 307-318.Publisher: Humana Press Country of Publication: United States NLM ID: 9214969 Publication Model: Print Cited Medium: Internet ISSN: 1940-6029

Record details

Improved LC-MS/MS method for the simultaneous quantification of tacrolimus and cyclosporine A in human blood and application to therapeutic drug monitoring.

• Authors : Chen F; Department of Clinical Pharmacy, Hunan University of Medicine General Hospital, Huaihua, China.; Yang X

Subjects: Cyclosporine* ; Tacrolimus*; Humans

• Source: Biomedical chromatography : BMC [Biomed Chromatogr] 2023 Dec; Vol. 37 (12), pp. e5751. Date of Electronic Publication: 2023 Sep 29.Publisher: Wiley Country of Publication: England NLM ID: 8610241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-0801

Record details

Cyclosporine A-enhanced cardioplegia preserves mitochondrial basal respiration after ischemic arrest.

• Authors : Hoyer AA; Department of Cardiac Surgery, University of Leipzig, Heart Center Leipzig, Helios Clinic, Leipzig, Germany.; Klaeske K

Subjects: Cyclosporine*/Cyclosporine*/Cyclosporine*/pharmacology ; Cyclosporine*/Cyclosporine*/Cyclosporine*/therapeutic use ; Myocardial Reperfusion Injury*/Myocardial Reperfusion Injury*/Myocardial Reperfusion Injury*/drug therapy

• Source: Perfusion [Perfusion] 2024 Jan; Vol. 39 (1), pp. 36-44. Date of Electronic Publication: 2021 Jun 30.Publisher: SAGE Publications Country of Publication: England NLM ID: 8700166 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details